Jupiter Life Line Hospitals Ltd. · NSE:JLHL
Jupiter Life Line Hospitals — Q2 & H1 FY25 Earnings Presentation
13 slides from Jupiter Life Line Hospitals's earnings presentation, Nov 8, 2024
Slide 1: Exchange filing cover letter
November 08, 2024 To, To, National Stock Exchange of India Ltd. BSE Limited Exchange Plaza, P.J. Towers, Bandra-Kurla Complex, 25th Floor, Dalal Street, Fort Bandra (East), Mumbai-400 051 Mumbai 400 001 Symbol: JLHL Code: 543980 Subject: Investor Presentation for the quarter and half year ended Sept
Slide 2: Results Presentation Q2 & H1 FY25
Bringing care into Healthcare. Results Presentation Q2 & H1 FY25
Slide 3: Safe Harbour
Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Jupiter Life Line Hospitals Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe
Slide 4: Management Commentary
Management Commentary Dr. Ankit Thakker ED & CEO “We are pleased to report a 20.5% increase in total income, reaching Rs 612.8 crore in H1FY25, up from Rs 508.4 crore in H1FY24. EBITDA rose by 22.3% to Rs 141.9 crore, compared to Rs 116.1 crore in H1FY24, while PAT grew by 9.6% to Rs 96.1 crore in H
Slide 5: Key Highlights of H1 FY25
Key Highlights of H1 FY25 Total Income EBITDA PAT Rs. 612.8 Cr Rs. 141.9 Cr Rs. 96.1 Cr 20.5 % YoY 22.3 % YoY 9.6 % YoY All three hospitals showed strong In the process of adding performance in H1 FY25, Construction of Dombivli Our 2nd unit at Pune is in 75 beds in Indore Hospital, In Q2 FY25, 22 be
Slide 6: H1 FY25 Performance Highlights
H1 FY25 Performance Highlights Rs in Crores Total Income EBITDA PBT PAT* +9.6% +20.5% +22.3% +71.9% 96.1 612.8 141.9 129.1 87.7 508.5 116.1 53.2 491.5 75.1 404.0 34.5 97.6 113.0 6.9 8.3 H1FY24 H1FY25 H1FY24 H1FY25 H1FY24* H1FY25 H1FY24 H1FY25 IPD OPD Others *PAT for H1FY24 includes a benefit of defe
Slide 7: H1 FY25 Operating Metrics
H1 FY25 Operating Metrics Operational Bed Capacity(1) Average Occupancy Rate(2) IPD & OPD Volumes (‘000)(3) Census Beds Non - Census Beds 961 983 67.2% 486.0 62.3% 435.7 27.2 IPD 24.3 829 851 OPD 411.4 458.8 132 132 H1FY24 H1FY25 H1FY24 H1FY25 H1FY24 H1FY25 ARPOB(4) ALOS (in Days)(5) Payor Mix Gover
Slide 8: Q2 FY25 Performance Highlights
Q2 FY25 Performance Highlights Rs in Crores Total Income EBITDA PBT PAT +22.7% +23.5% +66.6% +52.8% 324.2 76.6 68.9 51.5 264.2 62.0 33.7 41.4 261.6 210.6 29.6 50.2 58.4 4.1 3.4 4.2 Q2FY24 Q2FY25 Q2FY24 Q2FY25 Q2FY24 Q2FY25 Q2FY24* Q2FY25 IPD OPD Others *PAT for Q2FY24 includes a benefit of deferred
Slide 9: Operations at Distinct Geographies
Operations at 3 Distinct Geographies Operating Avg. ARPOB (3) Beds(1) Occupancy(2) Thane (2007) 377 72.0% 66,700 Pune (2017) 375 67.0% 55,000 Thane, Pune, Indore are accredited for NABH Digital Health - Gold Standard Indore (2020) 231 59.0% 44,700 As on 30th September’24 ARPOB rounded off to the nea
Slide 10: Consolidated Profit & Loss Statement
Consolidated Profit & Loss Statement Profit and Loss (in Rs. Crs) Q2FY25 Q2FY24 YoY Q1FY25 QoQ H1FY25 H1FY24 YoY FY24 Revenue from Operations 320.0 260.8 22.7% 284.5 12.5% 604.5 501.5 20.5% 1,059.8 Other Income - Operational 4.2 3.4 4.1 8.3 6.9 13.6 Total Income 324.2 264.2 22.7% 288.6 12.3% 612.8 5
Slide 11: Consolidated Balance Sheet
Consolidated Balance Sheet Equity & Liabilities (in Rs. Crs) Sep-24 Mar-24 Assets (in Rs. Crs) Sep-24 Mar-24 Total Equity 1,258.3 1,168.7 Non - Current Assets 964.6 871.6 Share Capital 65.6 65.6 Property Plant & Equipments 748.2 715.5 Other Equity 1,192.8 1,103.5 CWIP 135.1 74.0 Minority Interest -0
Slide 12: Consolidated Cash Flow Statement
Consolidated Cash Flow Statement Profit and Loss (in Rs. Crs) H1FY25 H1FY24 Net Profit Before Tax 129.1 75.1 Adjustments for: Non -Cash Items / Other Investment or Financial Items 20.3 44.2 Operating profit before working capital changes 149.4 119.3 Changes in working capital 1.8 -24.3 Cash generate
Slide 13: Patient First - Contact
PATIENT FIRST Jupiter Life Line Hospitals Limited CIN: L85100MH2002PLC137908 investor.relations@jupiterhospital.com http://www.sgapl.net/images/sgapl_logo.jpg Strategic Growth Advisors Pvt. Ltd. CIN: U74140MH2010PTC204285 Rahul Agarwal / Mandar Chavan rahul.agarwal@sgapl.net / mandar.chavan@sgapl.ne
Jupiter Life Line Hospitals — Q2 & H1 FY25 Earnings Presentation on 6ix